The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Me too - This was on the 25th Aug rns
Newcastle Premier Health Covid-19 Screening Programme
The Company announces the first commercial use of its Onsite ID app in partnership with its occupational health and wellness partner, Newcastle Premier Health Limited ("NPH").
NPH has completed the initial screening phase of its Access Control Programme for its customers. Onsite ID performs an integral part of the overall programme that helps businesses get employees back to work safely. Individual Covid-19 test results are set to be entered into the Onsite ID app which then will be used as a digital passport, enabling the users to share their Covid-19 status in a secure, immutable and GDPR compliant manner when meeting clients in person.
NPH's Access Control Programme is currently in progress and is expected to complete in the next three weeks. This will provide the Company with a useful case study for further sales and marketing activities.
So anytime now there should be some results and feedback from their new company
Whilst i do agree with some below as sp can get pumped, news should be due soon and people maybe taking position - im a little underwater so will welcome news or even a pump as this stops the sp from bucketing which knowone wants
Fantastic, a post from someone that has actually done some research as opposed to just spouting nonsense .......thank you Hendi.
I am of the opinion news is imminent.
Im a chartist - just been and looked and it did actually hit 9.8999 on the 28th April
Also if you read the last rns it stated Ctea was undergoing a test period which would be complete in 3 weeks. Im sure thats about now so could be an rns due in the next week or two
"never"
exactly
it did not hit 9.86p on 29th April.
It hit 7.12p on 29th April?
Where are you seeing this? Not that it matters now whatsoever
It hit 9.86 on 29 April
"when did this test 10p"
Never
when did this test 10p
Rock and huge demand.Last time we test 10p but we are much stronger position.Upward and onward.Massive opportunity.